Cite
HARVARD Citation
Larsen, J. et al. (n.d.). Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. American journal of hematology. 92 (8), pp. 759-763. [Online].